Trademark Details For KOMRILU (Serial Number 79280370)

  •  Home
  •  Print
KOMRILU
  • Rank
    Global Trademark Influence Ranking
    4947
0
0
0
0
Basic Information
Serial Number  United States - USPTO 79280370
Registration Number 6121500
Mark
KOMRILU
Filing Date Jan-13-2020
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  


  • GLAXO GROUP LIMITED


005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameMerilee J. Arevalo
AddressGSK LBP, 5.5A 5 MOORE DRIVE RESEARCH TRIANGLE PARK NC 27709-3398

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jul-28-2023CHANGE OF NAME/ADDRESS REC'D FROM IB   ADCHM
Dec-12-2020FINAL DECISION TRANSACTION PROCESSED BY IB   FINOP
Nov-24-2020FINAL DISPOSITION NOTICE SENT TO IB   FICSP
Nov-24-2020FINAL DISPOSITION PROCESSED   FIMPP
Nov-11-2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB   FICRP
Aug-11-2020REGISTERED-PRINCIPAL REGISTER   R.PRA
May-26-2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
May-26-2020PUBLISHED FOR OPPOSITION   PUBOA
May-06-2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Apr-18-2020REFUSAL PROCESSED BY IB   RFNTP
Apr-17-2020ASSIGNED TO LIE   ALIEA
Apr-08-2020APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-07-2020TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Apr-07-2020CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Apr-07-2020TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Mar-28-2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB   RFCSP
Mar-28-2020REFUSAL PROCESSED BY MPU   RFRRP
Mar-19-2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW   RFCRE
Mar-18-2020
NON-FINAL ACTION WRITTEN
  
CNRTR
Mar-15-2020ASSIGNED TO EXAMINER   DOCKD
Mar-13-2020APPLICATION FILING RECEIPT MAILED   MAFRO
Mar-09-2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-05-2020SN ASSIGNED FOR SECT 66A APPL FROM IB   REPRM